The latest price target for Guardant Health (NASDAQ:GH) was reported by Evercore ISI Group on April 6, 2026. The analyst firm set a price target for $90.00 expecting GH to rise to within 12 months (a possible 2.42% upside). 59 analyst firms have reported ratings in the last year.

The latest analyst rating for Guardant Health (NASDAQ:GH) was provided by Evercore ISI Group, and Guardant Health maintained their in-line rating.

The last upgrade for Guardant Health Inc happened on September 25, 2025 when Wolfe Research raised their price target to $75. Wolfe Research previously had a peer perform for Guardant Health Inc.

The last downgrade for Guardant Health Inc happened on January 5, 2026 when Evercore ISI Group changed their price target from $90 to $105 for Guardant Health Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Guardant Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Guardant Health was filed on April 6, 2026 so you should expect the next rating to be made available sometime around April 6, 2027.

While ratings are subjective and will change, the latest Guardant Health (GH) rating was a maintained with a price target of $110.00 to $90.00. The current price Guardant Health (GH) is trading at is $87.87, which is out of the analyst’s predicted range.